BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4175034)

  • 1. Effect of mestranol and chlormadinone acetate on urinary excretion of FSH and LH.
    Stevens VC; Goldzieher JW; Vorys N
    Am J Obstet Gynecol; 1968 Sep; 102(1):95-105. PubMed ID: 4175034
    [No Abstract]   [Full Text] [Related]  

  • 2. [The behavior of the gonadotropins FSH and LH during and after treatment with estrogenic and progestational drugs].
    Ramadori P; Lirosi G
    Patol Clin Ostet Ginecol; 1973; 1(1):26-34. PubMed ID: 4143256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Steroid metabolism in primates. XVIII. Return to higher levels of 17-ketosteroid excretion in urine after ending a long-term treatment with mestranol/chlormadinone acetate in the baboon].
    Gontscharow NP; Woronzow WI; Schön R; Hobe G; Schubert K
    Endokrinologie; 1976 Jul; 67(3):362-4. PubMed ID: 61857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunochemical determination of LH during therapy with oral and depot contraceptives].
    Tenhaeff D
    Arch Gynakol; 1971 Jun; 211(1):232. PubMed ID: 4103780
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations].
    Göretzlehner G; Wilken H
    Endokrinologie; 1972 Nov; 60(3):302-8. PubMed ID: 4121480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicle-stimulating hormone (FSH) and luteninizing hormone (LH) in the urine of prepubertal children.
    Rifkind AB; Kulin HE; Ross GT
    J Clin Invest; 1967 Dec; 46(12):1925-31. PubMed ID: 6073997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of various dosages of lynestrenol on the FSH, LH and total gonadotrophin activity during the menstrual cycle.
    Schmidt-Elmendorff H
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):368-73. PubMed ID: 5510165
    [No Abstract]   [Full Text] [Related]  

  • 9. Levels of serum follicle-stimulating hormone, luteinizing hormone, and plasma progestin during microdose chlormadinone treatment.
    Taymor ML; Levesque LA
    Fertil Steril; 1971 Jan; 22(1):1-8. PubMed ID: 4099041
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate].
    Zorrilla E
    Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
    Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in circulating LH level and in cervical mucus induced by mid-cycle progesterone in chimpanzees.
    Gould KG; Faulkner JR; Pernikoff D
    J Reprod Fertil; 1984 Mar; 70(2):379-85. PubMed ID: 6199496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
    Tyler ET
    Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of mestranol and chlormadinone acetate on basal and GnRH stimulated gonadotropin secretion in Turner's syndrome].
    Rudolf K; Kunkel S; Delzer W
    Zentralbl Gynakol; 1985; 107(23):1437-45. PubMed ID: 2420100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ovulation by estrogens.
    Gual C; Becerra C; Rice-Wray E; Goldzieher JW
    Am J Obstet Gynecol; 1967 Feb; 97(4):443-7. PubMed ID: 4163201
    [No Abstract]   [Full Text] [Related]  

  • 16. [Personal experience in the management of the post-menopausal patient using sequential 11 plus 10 therapy (mestranol 30 mcg. and chlormadinone 1 mlg. plus mestranol 80 mcg)].
    González Gutiérrez JT
    Ginecol Obstet Mex; 1969 May; 24(151):531-7. PubMed ID: 4186794
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience in the use of chlormadinone acetate-mestranol mixed tablet (S-3850 tablet)].
    Toyama J; Murata H; Itakura E; Sumi K; Sugawara T
    Sanfujinka No Jissai; 1967 Apr; 16(4):364-72. PubMed ID: 4168671
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the contraceptive effects of periodic administration of mestranol 0.08mg and chlormadinone acetate 2mg (S-3850 tablets)].
    Kobayashi T; Amemori Y; Watanabe T; Ichikawa T
    Horumon To Rinsho; 1968 May; 16(5):403-9. PubMed ID: 4177677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of the mixture of mestranol and chlormadinone for functional anomaly of the ovary].
    Kobayshi T; Amenomori Y; Nagai N; Egusa M; Ichikawa T
    Saishin Igaku; 1966 Sep; 21(9):2089-94. PubMed ID: 4166819
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the two-phase treatment with mestranol-chlormadinone acetate in dysfunctional hemorrhages, functional sterility and dys-or hypogonadotropic amenorrheas].
    Göretzlehner G
    Dtsch Gesundheitsw; 1967 Jun; 22(24):1124-6. PubMed ID: 4176451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.